Marta Bognar
Expertise in
12
conditions

Dr. Marta Bognar

Rheumatology
961 Smoky Mtn Spgs Lane Northeast, Suite A, 
Gainesville, GA 
Accepting New Patients
Offers Telehealth
42 Years of Experience
Expertise in
12
conditions
961 Smoky Mtn Spgs Lane Northeast, Suite A, 
Gainesville, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Marta Bognar is a Rheumatologist in Gainesville, Georgia. Dr. Bognar has been practicing medicine for over 42 years is highly rated in 12 conditions, according to our data. Her top areas of expertise are Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, Osteoporosis, and Psoriatic Arthritis. Dr. Bognar is currently accepting new patients.

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Medical University Of Budapest, 1984
Residency
Danbury Hospital, Internal Medicine
Specialties
Rheumatology
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine, Rheumatology - 1997
Fellowships
Emory University, Rheumatology, 1997
Hospital Affiliations
Northeast Georgia Medical Center, Inc
St Mary's Hospital
Chatuge Regional Hospital
Piedmont Athens Regional Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Arthritis Center of North Georgia
961 Smoky Mtn Spgs Lane Northeast, Suite A, Gainesville, GA 30501
Other Locations
Arthritis Center of North Georgia
957 Baxter Street, Athens, GA 30606

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Other, Biological
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 17, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
View 6 Less Clinical Trials

1 Total Publications

Multicentric reticulohistiocytosis post-COVID-19: a case report.
Multicentric reticulohistiocytosis post-COVID-19: a case report.
Journal: AME case reports
Published: August 28, 2023
Similar Doctors
Tracy Lovell
Expertise in
44
conditions
Dr. Tracy Lovell
Rheumatology
Expertise in
44
conditions
Dr. Tracy Lovell
Rheumatology

Northeast Georgia Diagnostic Associates And Clinic, LLC

1240 Jesse Jewell Parkway Southeast, Suite 500, 
Gainesville, GA 
 (0.4 miles away)
770-536-9864
Experience:
26+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tracy Lovell is a Rheumatologist in Gainesville, Georgia. Dr. Lovell has been practicing medicine for over 26 years is highly rated in 44 conditions, according to our data. Her top areas of expertise are Rheumatoid Arthritis (RA), Giant Cell Arteritis (GCA), Temporal Arteritis, and Juvenile Temporal Arteritis. Dr. Lovell is currently accepting new patients.

Alok Sachdeva
Expertise in
45
conditions
Dr. Alok Sachdeva
Rheumatology
Expertise in
45
conditions
Dr. Alok Sachdeva
Rheumatology

Northeast Georgia Diagnostic Associates And Clinic, LLC

1240 Jesse Jewell Parkway Southeast, Suite 500, 
Gainesville, GA 
 (0.4 miles away)
770-536-9864
Experience:
23+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alok Sachdeva is a Rheumatologist in Gainesville, Georgia. Dr. Sachdeva has been practicing medicine for over 23 years is highly rated in 45 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, and Psoriatic Arthritis. Dr. Sachdeva is currently accepting new patients.

Arezou Khosroshahi
Expertise in
13
conditions
Dr. Arezou Khosroshahi
Rheumatology
Expertise in
13
conditions
Dr. Arezou Khosroshahi
Rheumatology

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgA, 
Atlanta, GA 
 (46.4 miles away)
404-778-4366
Experience:
25+ years
Languages Spoken:
English, Farsi
See accepted insurances
Offers Telehealth

Arezou Khosroshahi is a Rheumatologist in Atlanta, Georgia. Dr. Khosroshahi has been practicing medicine for over 25 years is highly rated in 13 conditions, according to our data. Her top areas of expertise are IgG4-Related Disease, Lupus Nephritis, MAGIC Syndrome, and Light Chain Deposition Disease (LCDD).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bognar's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 29 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile